Through
4/26
As the pandemic continues and knowledge about it evolves, a team of researchers has worked to form a consensus on topics including intubation, high-flow nasal oxygen, and the use of personal protective equipment.
Resuscitation and survival rates are much higher than earlier reports of near-zero, and variation at the individual hospital level may have affected overall numbers.
Penn Medicine researchers have developed a unifying definition of “cytokine storm” to provide a framework to assess and treat patients whose immune systems have gone rogue.
Amidst the numerous challenges posed by COVID-19, the Penn Center for Innovation has continued to facilitate impactful innovations created at Penn, fostering partnerships and helping to realize new products and businesses.
All across the University, researchers have launched new areas of study, reaching across disciplinary boundaries to make stunning progress in combating COVID-19.
Drew Weissman of the Perelman School of Medicine, whose work is a key factor helping to enable two vaccines in late stages of testing, sheds light on the biology behind them and on his predictions about next steps in vaccine development and approval.
Emanuel has been tapped as member of a team of leading public health and scientific experts to advise on the Biden-Harris COVID-19 response.
Clinicians, engineers, and IT specialists work together at Penn on innovations that help doctors provide the best care for patients amid continued social distancing and coronavirus restrictions.
An international team including Penn demographer Michel Guillot found that from mid-February through May, 21 industrialized nations combined saw an 18% increase in deaths, or 206,000 more people dying from all causes than would have been expected had the pandemic not occurred.
Austin Kilaru, an LDI associate fellow and emergency physician, studied COVID-19 patients who return to the hospital after an initial evaluation in the emergency department, to understand how often people need hospitalization after initially appearing well.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →